Minakem is a cGMP custom manufacturer specialising in small molecule Active Pharmaceutical Ingredients (APIs), Highly Potent Active Pharmaceutical Ingredients (HPAPIs), and steroids. The company offers comprehensive Contract Development and Manufacturing Organisation (CDMO) services, underpinned by the expertise of highly skilled research and development teams. These teams are adept in process development, organic synthesis, and are bound by secrecy agreements to ensure the protection of intellectual property. With three production sites in Europe and one in Canada, Minakem is well-positioned to support strategic sourcing initiatives and reshoring activities. The company has recently launched several commercial generic APIs, including Apixaban, Mirabegron, Fulvestrant, and remifentanil, and also manufactures payload-linkers for antibody-drug conjugates (ADCs).

Services include:
- Contract Development and Manufacturing (CDMO)
- Custom manufacturing of small molecules APIs
- Production of Highly Potent Active Pharmaceutical Ingredients (HPAPIs)
- Development and manufacturing of steroids
- Analytical services
- Regulatory affairs support
- Expertise in process development and organic synthesis
- Protection of intellectual property through secrecy agreements

Minakem is recognized as a reliable partner for many of the largest pharmaceutical and biopharmaceutical companies, aiding them in the development and manufacturing of high-profile proprietary compounds. For more information, visit minakem.com.